Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Nymox to report results of new phase II study of NX-1207 in BPH

Jan. 21, 2008

Shire launches Fosrenol in Spain, completing launch roll-out in E.U. markets

Jan. 18, 2008

Vasopressin V2 receptor agonists prepared and tested at Kissei

Jan. 17, 2008

Lung and renal improvement with sirolimus in tuberous sclerosis complex and LAM / News in Context

Jan. 14, 2008

Phase III study of oxybutynin topical gel for OAB meets primary and secondary endpoints

Jan. 10, 2008

Protox reports positive final results from phase I study of PRX-302 for BPH

Jan. 7, 2008

Novel 5-HT2C receptor agonists emerge from Takeda R&D

Dec. 24, 2007

Recent Sumitomo Chemical patents disclose novel therapeutic agents for chronic renal failure

Dec. 21, 2007

ZymoGenetics and Merck Serono initiate phase II/III clinical trial of atacicept

Dec. 17, 2007

BioMarin enters research and option agreement with IGAN for IgA proteases

Dec. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...